Rain(2) | $58,000,000 | (Aug 29, 2025)
ALIGNMT AI | $6,500,000 | (Aug 29, 2025)
Matey AI | $7,500,000 | (Aug 29, 2025)
Certified by Founder
Lodge
ARTBIO
start up
United States
- Cambridge, Massachusetts
- 08/12/2023
- Series A
- $90,000,000
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.
- Industry Biotechnology Research
- Website https://artbio.com/
- LinkedIn https://www.linkedin.com/company/artbio-inc/
Related People
Emanuele OstuniFounder
Switzerland -
Reinach, Basel-Country
Specialties: Commercial execution, Strategy, M&A, Business Development, Entrepreneurship,
Ordinal | $1,000,000 | (Aug 29, 2025)
Cumin Co. | $1,500,000 | (Aug 29, 2025)
Nuyug | $285,129 | (Aug 29, 2025)
Maisa | $25,000,000 | (Aug 29, 2025)
Copper | $28,000,000 | (Aug 29, 2025)
PALMONAS | $6,269,923 | (Aug 29, 2025)
Sola(US) | $8,000,000 | (Aug 29, 2025)
Mantic | $4,000,000 | (Aug 29, 2025)
M0 | $40,000,000 | (Aug 29, 2025)